Eppendorf Cryotech Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Eppendorf Cryotech Limited - overview
Established
1994
Location
Maldon, -, UK
Primary Industry
Electronics
About
Based in Essex, UK, Eppendorf Cryotech Limited operates as a developer and manufacturer of instruments, consumables and services for laboratories. It offers products like pipettes, pipette tips, centrifuges, mixers, ultra-low temperature equipment, tubes, plates and cuvettes. It also provides services including qualification, calibration, preventative maintenance, repair and decontamination.
Primary Industry
Electronics
Sub Industries
Electronics, Electronic Components
Website
www.eppendorf.co.uk
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Eppendorf Cryotech Limited - financials
| Fiscal Year Ended | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
|---|---|---|---|---|---|---|
| Revenue (USD) | 11,337,490 | 13,744,331 | 15,291,984 | - | - | - |
| % Revenue Growth (YoY) | - | 21.2% | 11.3% | - | - | - |
| EBITDA (USD) | 484,568 | (77,866) | (294,647) | - | - | - |
| Operating Income (USD) | 75,637 | (539,691) | (788,416) | - | - | - |
| Operating Margin | 0.7% | (3.9%) | (5.2%) | - | - | - |
| % EBITDA Margin | 4.3% | (0.6%) | (1.9%) | - | - | - |
| NET Income (USD) | 82,093 | (547,473) | (871,181) | - | - | - |
| % Net Margin | 0.7% | (4.0%) | (5.7%) | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.